CurrentCardio coverage · page 2 of 9
JAMA Cardiology
Latest from JAMA Cardiology
JAMA Cardiol
Clinical Diagnosis of Calcium Release Deficiency Syndrome in a Family With Sudden Cardiac Death
Cohort studyArrhythmias & EP
JAMA Cardiol
JAMA Cardiol
Finerenone Across Cardiovascular-Kidney-Metabolic Syndrome Stages: Post Hoc Analysis of the FIDELITY Randomized Clinical Trials
Meta-analysisCardiometabolic & kidney
JAMA Cardiol
Maternal Diabetes and Risk of Early-Onset Cardiovascular Diseases in Offspring
Cohort studyCardiometabolic & kidney
JAMA Cardiol
Multiple Endotypes and Angina Burden in Patients With Nonobstructive Coronary Arteries
Cross-sectional studyCoronary & ACS
JAMA Cardiol
Non-HDL Cholesterol and Apolipoprotein B Measures and Risk of Atherosclerotic Cardiovascular Disease
Cohort studyPrevention & lipids
JAMA Cardiol
Pathological Analysis of Lipoprotein(a) Risk Variants and Culprit Coronary Thrombotic Lesions
Cross-sectional studyCoronary & ACS
JAMA Cardiol
Precardioversion Heart Rhythm Monitoring Using Smartphone Photoplethysmography: The SMARTBEATS Randomized Clinical Trial
Randomised controlled trialArrhythmias & EP
JAMA Cardiol
Projected US Cardiovascular Disease Burden From Heat Exposure for Future Greenhouse Gas Scenarios
Cross-sectional studyPrevention & lipids
JAMA Cardiol
Resuscitation Quality Improvement Program for CPR Training and Cardiac Arrest Survival in Hospitals
Cohort studyAcute care & resuscitation
JAMA Cardiol
Artificial Intelligence Electrocardiogram and Left Ventricular Systolic Dysfunction in Kenya
Diagnostic or prognostic studyHeart failure
JAMA Cardiol
JAMA Cardiol
JAMA Cardiol
Early Rule Out of Myocardial Infarction With a Novel High-Sensitivity Cardiac Troponin T Assay
Diagnostic or prognostic studyCoronary & ACS
JAMA Cardiol
Food Supplementation in Patients Hospitalized for Heart Failure: A Randomized Clinical Trial
Randomised controlled trialHeart failure
JAMA Cardiol
Myocardial Fibroblast Activation in Ischemic and Nonischemic Cardiomyopathy
Case-control studyHeart failure
JAMA Cardiol
Myocardial Fibrosis and Early Intervention in Asymptomatic Patients With Severe Aortic Stenosis: Insights From the EVOLVED Randomized Clinical Trial
Secondary analysisValvular & structural
JAMA Cardiol
Pregnancy-Associated Spontaneous Coronary Artery Dissection: A Report of the iSCAD Registry
Cohort studyCoronary & ACS
JAMA Cardiol
Response to PCSK9 Inhibition Based on LDL Receptor Function in Familial Hypercholesterolemia: A Nonrandomized Clinical Trial
Research articlePrevention & lipids
JAMA Cardiol
Time to Quadruple Therapy After Initial Diagnosis of Heart Failure With Reduced Ejection Fraction
Cohort studyHeart failure
JAMA Cardiol
Timeliness of Transthyretin Cardiac Amyloidosis Diagnosis in the Medicare Population
Cohort studyHeart failure
JAMA Cardiol
US Trends in Prescribing Nonstatin Lipid-Lowering Therapy, 2019-2024
Cross-sectional studyPrevention & lipids
JAMA Cardiol
Blood Pressure Genetic Risk and Incident Hypertension at 2 to 7 Years Post Partum
Cohort studyHypertension
JAMA Cardiol
Burst Exercise Stress Testing in Catecholaminergic Polymorphic Ventricular Tachycardia
Cohort studyArrhythmias & EP
JAMA Cardiol
Clonal Hematopoiesis and Risk of Incident Pericarditis and Myocarditis in 2 US Biobank Cohorts
Cohort studyCardio-oncology & other
JAMA Cardiol
Coronary Plaque Progression After Androgen Deprivation Therapy in Men With Prostate Cancer: A Randomized Clinical Trial
Randomised controlled trialCoronary & ACS
JAMA Cardiol
EMPEROR-Preserved Risk Model and Outcomes in the FINEARTS-HF Trial: A Prespecified Secondary Analysis of FINEARTS-HF
Secondary analysisHeart failure
JAMA Cardiol
Extended Low-Dose Apixaban and Superficial Vein Thrombosis: Post Hoc Analysis of the HI-PRO Randomized Clinical Trial
Secondary analysisPulmonary vascular & VTE
JAMA Cardiol
Oral Semaglutide and Change in Cardiovascular Risk Factors in High-Risk Type 2 Diabetes: A Post Hoc Secondary Analysis of the SOUL Randomized Clinical Trial
Secondary analysisCardiometabolic & kidney
JAMA Cardiol
Premature Menopause and Lifetime Risk of Coronary Heart Disease
Cohort studyPrevention & lipids
JAMA Cardiol
RBM20 Truncating Variants and Human Cardiomyopathy
Cohort studyHeart failure
JAMA Cardiol
Serum Neurofilament Light Chain and Cardiovascular Outcomes in Patients With Atrial Fibrillation
Cohort studyArrhythmias & EP
JAMA Cardiol
Conduction System vs Biventricular Pacing in Heart Failure: The PhysioSync-HF Randomized Clinical Trial
Randomised controlled trialHeart failure
JAMA Cardiol
Long-Term Outcomes of Left Bundle-Branch Pacing vs Biventricular Pacing in Heart Failure: The HeartSync-LBBP Randomized Clinical Trial
Randomised controlled trialHeart failure
JAMA Cardiol
Low-Dose Rivaroxaban to Prevent Left Ventricular Thrombosis After Anterior Myocardial Infarction: The APERITIF Randomized Clinical Trial
Randomised controlled trialCoronary & ACS
JAMA Cardiol
Management and Consequences of Genotype-Positive Familial Hypercholesterolemia
Cohort studyPrevention & lipids
JAMA Cardiol
JAMA Cardiol
Ticagrelor vs Prasugrel in Patients With Diabetes and Multivessel Coronary Artery Disease: The TUXEDO-2 Randomized Clinical Trial
Randomised controlled trialCoronary & ACS
JAMA Cardiol
Twenty-Year Follow-Up After Patent Foramen Ovale Closure in Patients With Paradoxical Embolism
Cohort studyValvular & structural
JAMA Cardiol
Cardiovascular-Kidney-Metabolic Medication Eligibility Across National Survey, Community-Based, and Ambulatory Healthcare Samples
Cross-sectional studyCardiometabolic & kidney